☰

David Rimm, Ph.D. - Publications

Affiliations: 
Southern Illinois University at Carbondale, Carbondale, IL 
Tree Info Similar researchers PubMed Report error

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Shafi S, Aung TN, Xirou V, Gavrielatou N, Vathiotis IA, Fernandez A, Moutafi M, Yaghoobi V, Herbst RS, Liu LN, Langermann S, Rimm DL. Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer. Laboratory Investigation; a Journal of Technical Methods and Pathology. 102: 1143-1149. PMID 35581307 DOI: 10.1038/s41374-022-00796-6  0.326
2022 Shafi S, Aung TN, Xirou V, Gavrielatou N, Vathiotis IA, Fernandez A, Moutafi M, Yaghoobi V, Herbst RS, Liu LN, Langermann S, Rimm DL. Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer. Laboratory Investigation; a Journal of Technical Methods and Pathology. 102: 1143-1149. PMID 35581307 DOI: 10.1038/s41374-022-00796-6  0.326
2022 Shafi S, Aung TN, Xirou V, Gavrielatou N, Vathiotis IA, Fernandez A, Moutafi M, Yaghoobi V, Herbst RS, Liu LN, Langermann S, Rimm DL. Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer. Laboratory Investigation; a Journal of Technical Methods and Pathology. 102: 1143-1149. PMID 35581307 DOI: 10.1038/s41374-022-00796-6  0.326
2020 Ahmed FS, Gaule P, McGuire J, Patel KK, Blenman KR, Pusztai L, Rimm DL. PD-L1 protein expression on both tumor cells and macrophages are associated with response to neoadjuvant durvalumab in triple negative breast cancer (TNBC). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32709714 DOI: 10.1158/1078-0432.CCR-20-1303  0.305
2020 Ding A, Villarroel-Espindola F, Ducler A, Henick BS, Desai S, Gianino N, Zugazagoitia J, Rimm DL, Robert A, Cruzalegui F, Ferré P, Herbst R, Sanmamed M, Chen L, Schalper KA. Abstract 5525: VISTA/PSGL1 axis as a dominant immunomodulatory pathway in human non-small cell lung cancer Immunology. 80: 5525-5525. DOI: 10.1158/1538-7445.Am2020-5525  0.306
2017 Pelekanou V, Carvajal-Hausdorf DE, Altan M, Wasserman B, Carvajal-Hausdorf C, Wimberly H, Brown J, Lannin D, Pusztai L, Rimm DL. Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance. Breast Cancer Research : Bcr. 19: 91. PMID 28784153 DOI: 10.1186/s13058-017-0884-8  0.31
2014 Wimberly H, Han G, Pinnaduwage D, Murphy LC, Yang XR, Andrulis IL, Sherman M, Figueroa J, Rimm DL. ERβ splice variant expression in four large cohorts of human breast cancer patient tumors. Breast Cancer Research and Treatment. 146: 657-67. PMID 25007965 DOI: 10.1007/s10549-014-3050-3  0.314
2014 Jeon YJ, Khelifa S, Feng Y, Lau E, Cardiff R, Kim H, Rimm DL, Kluger Y, Ronai Z. Abstract 2440: RNF5 mediates ER stress-induced degradation of SLC1A5 in breast cancer Cancer Research. 74: 2440-2440. DOI: 10.1158/1538-7445.Am2014-2440  0.302
2011 Michal AM, Peck AR, Tran TH, Liu C, Rimm DL, Rui H, Benovic JL. Differential expression of arrestins is a predictor of breast cancer progression and survival. Breast Cancer Research and Treatment. 130: 791-807. PMID 21318602 DOI: 10.1007/S10549-011-1374-9  0.31
2011 Peck A, Witkiewicz A, Liu C, Klimowicz A, Stringer G, Pequignot E, Freydin B, Yang N, Tran T, Rosenberg A, Hooke J, Kovatich A, Shriver C, Rimm D, Magliocco A, et al. P1-06-24: Nuclear Localization of Stat5a Predicts Response to Antiestrogen Therapy and Prognosis of Clinical Breast Cancer Outcome. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-06-24  0.304
2010 Neumeister V, Agarwal S, Bordeaux J, Camp RL, Rimm DL. In Situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis American Journal of Pathology. 176: 2131-2138. PMID 20228222 DOI: 10.2353/ajpath.2010.090712  0.304
2010 Nadler Y, González AM, Camp RL, Rimm DL, Kluger HM, Kluger Y. Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 21: 466-73. PMID 19717535 DOI: 10.1093/Annonc/Mdp346  0.316
2007 Pick E, Kluger Y, Giltnane JM, Moeder C, Camp RL, Rimm DL, Kluger HM. High HSP90 expression is associated with decreased survival in breast cancer. Cancer Research. 67: 2932-7. PMID 17409397 DOI: 10.1158/0008-5472.Can-06-4511  0.313
2007 Zerkowski MP, Camp RL, Burtness BA, Rimm DL, Chung GG. Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome. Cancer Investigation. 25: 19-26. PMID 17364553 DOI: 10.1080/07357900601128825  0.317
2005 Kluger HM, Chelouche Lev D, Kluger Y, McCarthy MM, Kiriakova G, Camp RL, Rimm DL, Price JE. Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease. Cancer Research. 65: 5578-87. PMID 15994930 DOI: 10.1158/0008-5472.Can-05-0108  0.308
Show low-probability matches.